We also confirmed the cellular expression of the top dysregulated genes (COL5A2, FC = 1.8, p = 0.0154 and RDX, FC = −1.5, p = 0.0106) in neurons and oligodendrocytes in brain tissues from MS patients (Fig. 2D–F). This evidence concerns the gene RDX and myeloid sarcoma.